5-Iodotubercidin
CAS No. 24386-93-4
5-Iodotubercidin ( NSC 113939 | 5-ITu )
产品货号. M17451 CAS No. 24386-93-4
5-Iodotubercidin 是一种有效的腺苷激酶抑制剂,IC50 为 26 nM。它抑制核苷转运蛋白、CK1、胰岛素受体酪氨酸激酶、磷酸化酶激酶、PKA、CK2 和 PKC。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥645 | 有现货 |
|
| 10MG | ¥1093 | 有现货 |
|
| 25MG | ¥2465 | 有现货 |
|
| 50MG | ¥3655 | 有现货 |
|
| 100MG | ¥5058 | 有现货 |
|
| 200MG | ¥7011 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥594 | 有现货 |
|
生物学信息
-
产品名称5-Iodotubercidin
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述5-Iodotubercidin 是一种有效的腺苷激酶抑制剂,IC50 为 26 nM。它抑制核苷转运蛋白、CK1、胰岛素受体酪氨酸激酶、磷酸化酶激酶、PKA、CK2 和 PKC。
-
产品描述5-Iodotubercidin is a potent adenosine kinase inhibitor with IC50 of 26 nM. It inhibits nucleoside transporter, CK1, insulin receptor tyrosine kinase, phosphorylase kinase, PKA, CK2 and PKC.
-
体外实验5-Iodotubercidin (NSC 113939) inhibits CK1, insulin receptor tyrosine kinase, phosphorylase kinase, PKA, CK2 and PKC, and the IC50 values are 0.4, 3.5, 5-10, 5-10, 10.9 and 27.7 μM respectively.5-Iodotubercidin (20 μM) causes an important decrease in ATP concentration, and a concomitant smaller increase in AMP concentration. 5-Iodotubercidin decreases the activity of ACC and the rates of synthesis of fatty acids and cholesterol. In line with the iodotubercidin-mediated inhibition of ACC, 5-iodotubercidin induces a marked decrease in the intracellular concentration of malonyl-CoA.
-
体内实验5-Iodotubercidin (1 mL/kg, i.p.) is in agreement with activity observed against bicuculline-induced seizures following local administration of the AKI into the prepiriform cortex.
-
同义词NSC 113939 | 5-ITu
-
通路Angiogenesis
-
靶点EGFR
-
受体adenosine kinase
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number24386-93-4
-
分子量392.15
-
分子式C11H13IN4O4
-
纯度>98% (HPLC)
-
溶解度DMSO : ≥ 49 mg/mL; 124.95 mM
-
SMILESNc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@H](O)C1O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Zhang X,etal.Identification of 5-Iodotubercidin as a genotoxic drug with anti-cancer potential. PLoS One. 2013 May 7;8(5):e62527.
021-51111890
购物车()
sales@molnova.cn

